Oncology Adjuvants Market Share

North American Market Forecasts

The market in the North America region is predicted to hold the highest CAGR of 35% during the prediction period. Factors such as the rising incidence of cancer, a large patient population, good healthcare facilities, and an emphasis on research and development can be attributed to this growth. In 2019, in the United States, it was reported that there were 1,752,735 new cancer cases recorded, and 599,589 individuals died from cancer reported as of the Center for Disease Control and Prevention statistics of June 2022. In addition, significant advances in healthcare technology and innovation have been made in North America. There is an established pharmaceutical and biotechnology sector in the region that contributes to developing new adjuvants and targeted treatments. The market growth is also supported by the adoption of advanced drug delivery systems and personalized approaches to medicine.

APAC Market Statistics

The market in the Asia Pacific region is set to grow notably during the time period between 2024- 2036. This growth can be attributed to an increase in per capita healthcare expenditure due to higher quality. The market opportunities are expected to be expanded by increasing R&D initiatives and increased demand for cancer treatments in this area. Moreover, the market's growth is supported by a growing number of cancer hospitals and an increased acceptance of new technology.